AKT1 and non-small cell lung carcinoma: Furthermore, Akt was shown to be highly expressed in bronchial premalignancies and most non-small cell lung cancers (NSCLC), where it can induce malignant transformation, invasiveness, metastatic growth, and inhibition of programmed cell death [29,75,76].